Disrupting SEs by BRD4 inhibitors potently suppressed self-renewal, invasive growth, lymph node metastasis of CSC, and at last eliminated CSCs from human HNSCC [151]. Here, BRD4 is linked to head and neck squamous cell carcinoma.